Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Roffi

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Journal of Interferon Research|August 1, 1994
Clinical significance of recombinant interferon-alpha 2 neutralizing antibodies in hepatitis patientsG Antonelli, G Giannelli, M Pistello, et al.
Journal of Hepatology|February 2, 1999
Early effects of total paracentesis and albumin infusion on muscle sympathetic nerve activity in cirrhotic patients with tense ascitesM Pozzi, G Grassi, V Pecci, et al.
Hepatology (Baltimore, Md.)|March 1, 1995
Breakthrough during recombinant interferon alfa therapy in patients with chronic hepatitis C virus infection: prevalence, etiology, and managementL Roffi, G C Mels, G Antonelli, et al.
Gastroenterology|March 1, 1994
Time course of circulatory and humoral effects of rapid total paracentesis in cirrhotic patients with tense, refractory ascitesM Pozzi, G Osculati, G Boari, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 1, 2005
Interferon-induced depression: prevalence and managementA Scalori, M Pozzi, V Bellia, et al.
The American Journal of Gastroenterology|September 11, 1998
HCV genotypes and breakthrough in patients treated with recombinant alpha interferonL Roffi, G Colloredo, B Brugnetti, et al.
Clinical and Experimental Immunology|June 1, 1996
Antibodies to interferon (IFN) in hepatitis C patients relapsing while continuing recombinant IFN-alpha2 therapyG Antonelli, G Giannelli, M Currenti, et al.
Progress in Clinical and Biological Research|January 1, 1993
Lymphoblastoid interferon in patients with chronic nAnB hepatitis showing relapse during recombinant alpha interferon therapyG C Mels, L Roffi, G Antonelli, et al.
Liver|August 1, 1996
Iron stores, response to alpha-interferon therapy, and effects of iron depletion in chronic hepatitis CA Piperno, M Sampietro, R D'Alba, et al.
The American Journal of Gastroenterology|May 26, 2001
Hepatocyte proliferation and risk of hepatocellular carcinoma in cirrhotic patientsA Sangiovanni, E Colombo, F Radaelli, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Journal of Interferon Research|August 1, 1994
Clinical significance of recombinant interferon-alpha 2 neutralizing antibodies in hepatitis patientsG Antonelli, G Giannelli, M Pistello, et al.
Journal of Hepatology|February 2, 1999
Early effects of total paracentesis and albumin infusion on muscle sympathetic nerve activity in cirrhotic patients with tense ascitesM Pozzi, G Grassi, V Pecci, et al.
Hepatology (Baltimore, Md.)|March 1, 1995
Breakthrough during recombinant interferon alfa therapy in patients with chronic hepatitis C virus infection: prevalence, etiology, and managementL Roffi, G C Mels, G Antonelli, et al.
Gastroenterology|March 1, 1994
Time course of circulatory and humoral effects of rapid total paracentesis in cirrhotic patients with tense, refractory ascitesM Pozzi, G Osculati, G Boari, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 1, 2005
Interferon-induced depression: prevalence and managementA Scalori, M Pozzi, V Bellia, et al.
The American Journal of Gastroenterology|September 11, 1998
HCV genotypes and breakthrough in patients treated with recombinant alpha interferonL Roffi, G Colloredo, B Brugnetti, et al.
Clinical and Experimental Immunology|June 1, 1996
Antibodies to interferon (IFN) in hepatitis C patients relapsing while continuing recombinant IFN-alpha2 therapyG Antonelli, G Giannelli, M Currenti, et al.
Progress in Clinical and Biological Research|January 1, 1993
Lymphoblastoid interferon in patients with chronic nAnB hepatitis showing relapse during recombinant alpha interferon therapyG C Mels, L Roffi, G Antonelli, et al.
Liver|August 1, 1996
Iron stores, response to alpha-interferon therapy, and effects of iron depletion in chronic hepatitis CA Piperno, M Sampietro, R D'Alba, et al.
The American Journal of Gastroenterology|May 26, 2001
Hepatocyte proliferation and risk of hepatocellular carcinoma in cirrhotic patientsA Sangiovanni, E Colombo, F Radaelli, et al.
Pageof 4